MediSieve
Elinor Jones has several years of experience in regulatory affairs. Elinor is currently working as a Regulatory Affairs Manager at MediSieve, starting in January 2022. Prior to that, they worked at Prism Medical UK from November 2020 to March 2022 as a Regulatory Affairs Manager. Elinor also had a role as a Senior Regulatory Affairs Specialist at ConvaTec from April 2020 to November 2020, and as a Regulatory Affairs Specialist from March 2015 to April 2020. Their early experience in the field includes a role as a Laboratory based production co-ordinator at Mcdiagnostics from 2012 to 2013. Additionally, Elinor worked as a Regulatory Vigilance Evaluator at ConvaTec from September 2013 to March 2015, where they reviewed complaint cases and prepared vigilance reports for national competent authorities/regulatory bodies.
Elinor Jones pursued their undergraduate education from 2009 to 2012 at The University of Manchester, where they obtained a degree in Biomedical Sciences with a focus on Life Sciences.
This person is not in any teams
MediSieve
1 followers
MediSieve is a multi-award-winning medical device company developing Magnetic Blood Filtration (MBF), a platform technology for the treatment of blood-borne diseases by physically removing disease relevant targets directly from a patient’s bloodstream. MBF is an extracorporeal technology, similar to dialysis. A patient's blood is continuouslycirculated through an external blood loop containing the MediSieve system. Targeted magnetic particles (TB-MPs) are infused into the loop, binding specifically to disease-relevant targets in the patient's blood. The blood then flows through a magnetic filter which captures the particles and bound targets and the remainder of the blood returns to the patient unaffected; the TB-MPs never enter the patient’s body.MediSieve is based at the Imperial Incubator in White City, London. It has dedicated workshop and laboratory facilities (including capacity for ELISAs, Flow Cytometry and human blood testing) in which products are developed and validated.